Oventus Medical Ltd

ASX:OVN ISIN:AU000000OVN3

Oventus Medical Ltd (ASX:OVN) is a Brisbane, Australia, based medical device company that has commercialized and brought to market a new sleep treatment platform for the treatment of sleep apnoea and snoring that enhances the treatment outcomes of both oral appliance therapy and CPAP therapy through increased efficacy and greater adherence.

       

News

Oventus Medical Ltd (ASX:OVN) Airway Technology Achieves Positive Clinical Trial

🕔5/22/2018 10:21:38 AM 706

Oventus Medical Ltd (ASX:OVN) is pleased to announce the results of the OVEN-003 clinical trial study being conducted in Brisbane by the company, a randomised controlled clinical trial examining the treatment outcomes of oral appliance therapy with and without 'Oventus Airway Technology'.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Quarterly Business Review

🕔4/23/2018 9:29:36 AM 1395

Oventus Medical Ltd (ASX:OVN) announces its Appendix 4C Report for the three-month period ending 31 March 2018 (Q3 FY2018) and is pleased to provide a review of progress made during the quarter.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Investor Presentation

🕔9/27/2017 8:23:33 AM 3610

Oventus Medical Ltd (ASX:OVN) provide the latest Investor Presentation.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Audited Financial Statements and Appendix 4E

🕔8/31/2017 1:27:22 PM 4052

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to release its Appendix 4E with its full year audited general purpose financial report for the period ending 30 June 2017.

Read Full Article

FINANCE VIDEO: Oventus Medical Ltd (ASX:OVN) Financial News Network Interview

🕔8/24/2017 10:00:45 AM 6812

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to share Dr Chris Hart's interview on Financial News Network.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Appendix 4C - Quarterly Cash Flow Report

🕔7/31/2017 9:45:46 AM 3835

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has today released its Appendix 4C - Quarterly cash flow report for the period ended 30 June 2017.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Extension of Share Purchase Plan

🕔7/14/2017 11:26:52 AM 2490

Oventus Medical Limited (ASX:OVN) announced a share purchase plan to the market on 22 June 2017. Oventus wishes to advise that the closing date for the SPP will be extended from Wednesday 19 July 2017 to Monday 31 July 2017.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Receives FDA Clearance for the O2Vent W

🕔7/12/2017 9:29:37 AM 2466

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has received FDA 510k clearance for its O2Vent W device, an oral appliance intended to reduce or alleviate snoring and mild to moderate obstructive sleep apnoea.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Share Purchase Plan Documents Issued to Shareholders

🕔6/27/2017 10:02:34 AM 2463

Oventus Medical Ltd (ASX:OVN) announced a share purchase plan to the market on 22 June 2017. The record date to be registered as a shareholder for participation in the SPP is Wednesday, 21 June 2017.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Successful Capital Raising

🕔6/22/2017 10:07:35 AM 2567

Oventus Medical Limited (ASX:OVN) announces that it has completed a first tranche placement of approximately 18 million shares to institutional and sophisticated investors at an issue price of $0.36 per share to raise approximately $6.5 million.

Read Full Article
###

10,476 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 302) (Last 30 Days: 709) (Since Published: 10476) 

Markets ASX:OVN

Company Data

    Headquarters
  • 1 Swann Road
    Indooroopilly
    PO Box 190, Indooroopilly
    4068 QLD Australia
  • Telephone
  • 1300 533 159 
  • Principal Sector
  • Chemical Equipment & Manufacturing 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.oventus.com.au

Company Reports

Presentations

Quarterly Report

Social Media